REGENXBIO INC's ticker is and the CUSIP is 75901B957. A total of 3 filers reported holding REGENXBIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,646 | -98.0% | 100 | -97.6% | 0.00% | – |
| Q2 2023 | $81,959 | +20.5% | 4,100 | +36.7% | 0.00% | – |
| Q4 2022 | $68,040 | -80.0% | 3,000 | -76.7% | 0.00% | -100.0% |
| Q3 2022 | $341,000 | +150.7% | 12,900 | +134.5% | 0.00% | – |
| Q2 2022 | $136,000 | -78.3% | 5,500 | -70.9% | 0.00% | -100.0% |
| Q1 2022 | $627,000 | +200.0% | 18,900 | +195.3% | 0.00% | – |
| Q4 2021 | $209,000 | -96.1% | 6,400 | -95.0% | 0.00% | -100.0% |
| Q3 2021 | $5,378,000 | +9859.3% | 128,300 | +9064.3% | 0.01% | – |
| Q2 2021 | $54,000 | -76.4% | 1,400 | -79.1% | 0.00% | – |
| Q1 2021 | $229,000 | -3.0% | 6,700 | +4.7% | 0.00% | -100.0% |
| Q2 2020 | $236,000 | -74.9% | 6,400 | -77.9% | 0.00% | -87.5% |
| Q1 2020 | $939,000 | -15.4% | 29,000 | +7.0% | 0.01% | 0.0% |
| Q4 2019 | $1,110,000 | +2746.2% | 27,100 | +2363.6% | 0.01% | – |
| Q3 2019 | $39,000 | -98.6% | 1,100 | -97.9% | 0.00% | -100.0% |
| Q2 2019 | $2,712,000 | +16.2% | 52,800 | +29.7% | 0.02% | -3.8% |
| Q1 2019 | $2,333,000 | -7.2% | 40,700 | -32.1% | 0.03% | +18.2% |
| Q4 2018 | $2,513,000 | +1564.2% | 59,900 | +2895.0% | 0.02% | +2100.0% |
| Q3 2018 | $151,000 | -59.5% | 2,000 | -61.5% | 0.00% | -66.7% |
| Q2 2018 | $373,000 | +131.7% | 5,200 | -3.7% | 0.00% | +50.0% |
| Q1 2018 | $161,000 | – | 5,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $1,646 | 0.00% |
| SIMPLEX TRADING, LLC | 2,500 | $41 | 0.00% |